BlackRock’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.5M Sell
2,107,008
-4,097,776
-66% -$2.93M ﹤0.01% 4069
2025
Q1
$4.04M Sell
6,204,784
-1,388,407
-18% -$903K ﹤0.01% 3676
2024
Q4
$14M Buy
7,593,191
+577,072
+8% +$1.06M ﹤0.01% 3207
2024
Q3
$24.3M Buy
7,016,119
+105,389
+2% +$365K ﹤0.01% 2862
2024
Q2
$20.2M Buy
6,910,730
+1,208,825
+21% +$3.54M ﹤0.01% 2937
2024
Q1
$32.2M Sell
5,701,905
-122,017
-2% -$689K ﹤0.01% 2658
2023
Q4
$25M Sell
5,823,922
-162,678
-3% -$698K ﹤0.01% 2828
2023
Q3
$20.8M Sell
5,986,600
-18,957
-0.3% -$65.8K ﹤0.01% 2877
2023
Q2
$27.9M Buy
6,005,557
+984,734
+20% +$4.58M ﹤0.01% 2766
2023
Q1
$23.2M Buy
5,020,823
+160,683
+3% +$742K ﹤0.01% 2843
2022
Q4
$39.3M Buy
4,860,140
+851,770
+21% +$6.88M ﹤0.01% 2597
2022
Q3
$22.2M Buy
4,008,370
+285,745
+8% +$1.59M ﹤0.01% 2930
2022
Q2
$19.4M Sell
3,722,625
-6,204
-0.2% -$32.3K ﹤0.01% 3045
2022
Q1
$30.7M Buy
3,728,829
+28,786
+0.8% +$237K ﹤0.01% 2837
2021
Q4
$55.1M Buy
3,700,043
+43,566
+1% +$648K ﹤0.01% 2572
2021
Q3
$69.1M Buy
3,656,477
+29,678
+0.8% +$561K ﹤0.01% 2413
2021
Q2
$67.4M Buy
3,626,799
+524,826
+17% +$9.76M ﹤0.01% 2467
2021
Q1
$70.6M Buy
3,101,973
+384,044
+14% +$8.74M ﹤0.01% 2367
2020
Q4
$59M Buy
2,717,929
+670,366
+33% +$14.6M ﹤0.01% 2333
2020
Q3
$20.6M Buy
2,047,563
+1,087,322
+113% +$10.9M ﹤0.01% 2778
2020
Q2
$7.45M Buy
960,241
+299,490
+45% +$2.32M ﹤0.01% 3291
2020
Q1
$6.74M Buy
660,751
+13,644
+2% +$139K ﹤0.01% 3153
2019
Q4
$7.12M Buy
647,107
+3,088
+0.5% +$34K ﹤0.01% 3353
2019
Q3
$5.85M Buy
644,019
+99,871
+18% +$908K ﹤0.01% 3395
2019
Q2
$6.19M Buy
544,148
+228,480
+72% +$2.6M ﹤0.01% 3425
2019
Q1
$3.6M Sell
315,668
-94,045
-23% -$1.07M ﹤0.01% 3488
2018
Q4
$3.7M Buy
409,713
+69,813
+21% +$630K ﹤0.01% 3460
2018
Q3
$5.1M Buy
+339,900
New +$5.1M ﹤0.01% 3461